Gene · 3959
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycoproteomic Analysis of Urinary Extracellular Vesicles for Biomarkers of Hepatocellular Carcinoma. | Molecules | 2023 | 36770959 | PubTator, text mining | PubMed |
| Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice. | Int J Mol Sci | 2023 | 36769148 | PubTator, text mining | PubMed |
| Macrophage Phenotyping in Atherosclerosis by Proteomics. | Int J Mol Sci | 2023 | 36768933 | PubTator, text mining | PubMed |
| Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential. | Int J Mol Sci | 2023 | 36768435 | PubTator, text mining | PubMed |
| Identification of Highly Sensitive Pleural Effusion Protein Biomarkers for Malignant Pleural Mesothelioma by Affinity-Based Quantitative Proteomics. | Cancers (Basel) | 2023 | 36765599 | PubTator, text mining | PubMed |
| Establishment of a novel 70K Mac-2 binding protein antibody through screening of fucosylation-related antibodies. | J Biochem | 2023 | 36760066 | PubTator, text mining | PubMed |
| Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis. | J Gastroenterol | 2023 | 36729172 | PubTator, text mining | PubMed |
| Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach. | Adv Cancer Res | 2023 | 36725111 | PubTator, text mining | PubMed |
| The pleiotropic role of galectin-3 in melanoma progression: Unraveling the enigma. | Adv Cancer Res | 2023 | 36725108 | PubTator, text mining | PubMed |
| Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19. | J Thromb Haemost | 2023 | 36716966 | PubTator, text mining | PubMed |
| Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C. | Viruses | 2023 | 36680221 | PubTator, text mining | PubMed |
| Electrochemical (Bio)Sensing Devices for Human-Microbiome-Related Biomarkers. | Sensors (Basel) | 2023 | 36679633 | PubTator, text mining | PubMed |
| Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral. | Cancers (Basel) | 2023 | 36672412 | PubTator, text mining | PubMed |
| CircZBTB46 Protects Acute Myeloid Leukemia Cells from Ferroptotic Cell Death by Upregulating SCD. | Cancers (Basel) | 2023 | 36672408 | PubTator, text mining | PubMed |
| O-Glycomic and Proteomic Signatures of Spontaneous and Butyrate-Stimulated Colorectal Cancer Cell Line Differentiation. | Mol Cell Proteomics | 2023 | 36669592 | PubTator, text mining | PubMed |
| Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis. | Rheumatology (Oxford) | 2023 | 36661295 | PubTator, text mining | PubMed |
| An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer. | Commun Biol | 2023 | 36653467 | PubTator, text mining | PubMed |
| The Renaissance of Male Infertility Management in the Golden Age of Andrology. | World J Mens Health | 2023 | 36649928 | PubTator, text mining | PubMed |
| Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice. | Proteomes | 2023 | 36648960 | PubTator, text mining | PubMed |
| The interferon stimulated gene-encoded protein HELZ2 inhibits human LINE-1 retrotransposition and LINE-1 RNA-mediated type I interferon induction. | Nat Commun | 2023 | 36639706 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3959/papers?page=22